Shots:
- The US FDA has approved ECoG Assistant, an AI-powered clinician tool designed to support epilepsy management using data from the RNS System, with NeuroPace debuting the tool at ASSFN’26
- ECoG Assistant was developed using 124,450 epileptologist-labeled intracranial EEG records & identifies ECoGs of Interest, enabling clinicians to review long-term EEG trends & circadian activity patterns more efficiently
- NeuroPace also submitted its cloud-based Patient Data Management System (PDMS) for FDA review to modernize the underlying software infrastructure that supports the RNS System, with decision expected in Q2’26
Ref: Businesswire | Image: NeuroPace | Press Release
Related News: Cardiosense Receives FDA De Novo Classification for its PCWP Analysis Software
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
